MedTrace Logo

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

NCT02614703 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-08-27

Study results available
· View outcomes & findings →

Summary

Neoplasia in Barrett's esophagus could be missed during routine random biopsies. We propose a study using chromoendoscopy with Acetic Acid to increase the yield of biopsies in detecting neoplasia.

Conditions

  • Barrett's Esophagus

Interventions

DRUG

Chromoendoscopy using Acetic Acid 2.5%

Spraying esophageal mucosa during random biopsies for Barrett's esophagus

OTHER

Standard random esophageal biopsies

Random esophageal biopsies performed as per protocol

Sponsors & Collaborators

  • DHR Health Institute for Research and Development

    lead OTHER

Principal Investigators

  • Ingrid M Chacon, MD · Doctor's Hospital at Renaissance

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-10
Primary Completion
2018-07-30
Completion
2018-07-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02614703 on ClinicalTrials.gov